OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of carnitine supplementation on NAFLD: a systematic review and meta-analysis
Aiping Liu, Yitong Cai, Yuan Yuan, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8

Showing 8 citing articles:

Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease
Rong Ma, Guang-Ying Shi, Yanfang Li, et al.
British Journal Of Nutrition (2024) Vol. 131, Iss. 11, pp. 1915-1923
Open Access | Times Cited: 9

Mitochondrial dysfunction in drug-induced hepatic steatosis: recent findings and current concept
Annie Borgne‐Sanchez, Bernard Fromenty
Clinics and Research in Hepatology and Gastroenterology (2025) Vol. 49, Iss. 3, pp. 102529-102529
Closed Access | Times Cited: 1

Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease
Mareca Lodge, Rachel Dykes, Arion Kennedy
Biomolecules (2024) Vol. 14, Iss. 7, pp. 845-845
Open Access | Times Cited: 7

The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
Chi Zhang, X Yang, Yi Xue, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access

Efficacy of metformin versus l‐carnitine in vitamin E‐treated patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial
Manouchehr Khoshbaten, Elnaz Shaseb, Samineh Beheshtirouy, et al.
Advances in digestive medicine (2025)
Closed Access

Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction–associated steatohepatitis
Junyan Lyu, Hikari Okada, Hajime Sunagozaka, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 3

Page 1

Scroll to top